XNK Therapeutics Competitors and Similar CompaniesClear all

XNK Therapeutics's competitors and similar companies include Pharmstandard, Agios Pharmaceuticals and Debiopharm.

	XNK Therapeutics XNK Therapeutics (formerly CellProtect Nordic Pharmaceuticals) is a pharmaceutical company developing cell-based therapies for the treatment of severe diseases.	Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.	Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.	Debiopharm Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections.
Founding Date	Founding Date 2013	Founding Date 2003	Founding Date 2008	Founding Date 1979
Type	Type Private	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development oncology pharma
Locations	Locations Huddinge, SE HQ	Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Petrovo Dalnee, RU Tomsk, RU Ufa, RU Vol'ginskii, RU	Locations Cambridge, US HQ	Locations Lausanne, CH HQ Oss, NL
Employees	Employees 9	Employees 1,77814% increase	Employees 53611% increase	Employees 4771% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₽152.1b (FY, 2024)	Revenue (est.) $54m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ₽117b (FY, 2024)	Cost of goods $6.3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ₽35.2b (FY, 2024)	Gross profit $47.7m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ₽22.7b (FY, 2024)	Net income ($412.8m) (FY, 2025)	Net income N/A